199 related articles for article (PubMed ID: 25122464)
1. Lower intensified target LDL-c level of statin therapy results in a higher risk of incident diabetes: a meta-analysis.
Cai R; Yuan Y; Zhou Y; Xia W; Wang P; Sun H; Yang Y; Huang R; Wang S
PLoS One; 2014; 9(8):e104922. PubMed ID: 25122464
[TBL] [Abstract][Full Text] [Related]
2. Statins worsen glycemic control of T2DM in target LDL-c level and LDL-c reduction dependent manners: a meta-analysis.
Cai R; Yuan Y; Sun J; Xia W; Huang R; Tian S; Dong X; Shen Y; Wang S
Expert Opin Pharmacother; 2016 Oct; 17(14):1839-49. PubMed ID: 27488607
[TBL] [Abstract][Full Text] [Related]
3. Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis.
Sun H; Yuan Y; Wang P; Cai R; Xia W; Huang R; Wang S
Lipids Health Dis; 2015 Nov; 14():140. PubMed ID: 26526340
[TBL] [Abstract][Full Text] [Related]
4. Association between reductions in low-density lipoprotein cholesterol with statin therapy and the risk of new-onset diabetes: a meta-analysis.
Wang S; Cai R; Yuan Y; Varghese Z; Moorhead J; Ruan XZ
Sci Rep; 2017 Jan; 7():39982. PubMed ID: 28071756
[TBL] [Abstract][Full Text] [Related]
5. Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Khan SU; Rahman H; Okunrintemi V; Riaz H; Khan MS; Sattur S; Kaluski E; Lincoff AM; Martin SS; Blaha MJ
J Am Heart Assoc; 2019 Apr; 8(7):e011581. PubMed ID: 30898075
[TBL] [Abstract][Full Text] [Related]
6. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.
Sattar N; Preiss D; Murray HM; Welsh P; Buckley BM; de Craen AJ; Seshasai SR; McMurray JJ; Freeman DJ; Jukema JW; Macfarlane PW; Packard CJ; Stott DJ; Westendorp RG; Shepherd J; Davis BR; Pressel SL; Marchioli R; Marfisi RM; Maggioni AP; Tavazzi L; Tognoni G; Kjekshus J; Pedersen TR; Cook TJ; Gotto AM; Clearfield MB; Downs JR; Nakamura H; Ohashi Y; Mizuno K; Ray KK; Ford I
Lancet; 2010 Feb; 375(9716):735-42. PubMed ID: 20167359
[TBL] [Abstract][Full Text] [Related]
7. Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials.
Lee M; Cheng CY; Wu YL; Lee JD; Hsu CY; Ovbiagele B
JAMA Neurol; 2022 Apr; 79(4):349-358. PubMed ID: 35188949
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature.
Yu M; Liang C; Kong Q; Wang Y; Li M
Lipids Health Dis; 2020 Jan; 19(1):1. PubMed ID: 31900179
[TBL] [Abstract][Full Text] [Related]
9. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.
Preiss D; Seshasai SR; Welsh P; Murphy SA; Ho JE; Waters DD; DeMicco DA; Barter P; Cannon CP; Sabatine MS; Braunwald E; Kastelein JJ; de Lemos JA; Blazing MA; Pedersen TR; Tikkanen MJ; Sattar N; Ray KK
JAMA; 2011 Jun; 305(24):2556-64. PubMed ID: 21693744
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials.
Josan K; Majumdar SR; McAlister FA
CMAJ; 2008 Feb; 178(5):576-84. PubMed ID: 18299547
[TBL] [Abstract][Full Text] [Related]
11. Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials.
Rahal AJ; ElMallah AI; Poushuju RJ; Itani R
Saudi Med J; 2016 Oct; 37(10):1051-60. PubMed ID: 27652354
[TBL] [Abstract][Full Text] [Related]
12. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.
Navarese EP; Robinson JG; Kowalewski M; Kolodziejczak M; Andreotti F; Bliden K; Tantry U; Kubica J; Raggi P; Gurbel PA
JAMA; 2018 Apr; 319(15):1566-1579. PubMed ID: 29677301
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
14. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials.
Zaccardi F; Kunutsor SK; Seidu S; Davies MJ; Khunti K
Atherosclerosis; 2018 Apr; 271():223-231. PubMed ID: 29524865
[TBL] [Abstract][Full Text] [Related]
15. Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials.
Koskinas KC; Siontis GCM; Piccolo R; Mavridis D; Räber L; Mach F; Windecker S
Eur Heart J; 2018 Apr; 39(14):1172-1180. PubMed ID: 29069377
[TBL] [Abstract][Full Text] [Related]
16. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Jamialahmadi T; Baratzadeh F; Reiner Ž; Simental-Mendía LE; Xu S; Susekov AV; Santos RD; Sahebkar A
Mediators Inflamm; 2021; 2021():9661752. PubMed ID: 34526854
[TBL] [Abstract][Full Text] [Related]
18. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.
Swerdlow DI; Preiss D; Kuchenbaecker KB; Holmes MV; Engmann JE; Shah T; Sofat R; Stender S; Johnson PC; Scott RA; Leusink M; Verweij N; Sharp SJ; Guo Y; Giambartolomei C; Chung C; Peasey A; Amuzu A; Li K; Palmen J; Howard P; Cooper JA; Drenos F; Li YR; Lowe G; Gallacher J; Stewart MC; Tzoulaki I; Buxbaum SG; van der A DL; Forouhi NG; Onland-Moret NC; van der Schouw YT; Schnabel RB; Hubacek JA; Kubinova R; Baceviciene M; Tamosiunas A; Pajak A; Topor-Madry R; Stepaniak U; Malyutina S; Baldassarre D; Sennblad B; Tremoli E; de Faire U; Veglia F; Ford I; Jukema JW; Westendorp RG; de Borst GJ; de Jong PA; Algra A; Spiering W; Maitland-van der Zee AH; Klungel OH; de Boer A; Doevendans PA; Eaton CB; Robinson JG; Duggan D; ; ; ; Kjekshus J; Downs JR; Gotto AM; Keech AC; Marchioli R; Tognoni G; Sever PS; Poulter NR; Waters DD; Pedersen TR; Amarenco P; Nakamura H; McMurray JJ; Lewsey JD; Chasman DI; Ridker PM; Maggioni AP; Tavazzi L; Ray KK; Seshasai SR; Manson JE; Price JF; Whincup PH; Morris RW; Lawlor DA; Smith GD; Ben-Shlomo Y; Schreiner PJ; Fornage M; Siscovick DS; Cushman M; Kumari M; Wareham NJ; Verschuren WM; Redline S; Patel SR; Whittaker JC; Hamsten A; Delaney JA; Dale C; Gaunt TR; Wong A; Kuh D; Hardy R; Kathiresan S; Castillo BA; van der Harst P; Brunner EJ; Tybjaerg-Hansen A; Marmot MG; Krauss RM; Tsai M; Coresh J; Hoogeveen RC; Psaty BM; Lange LA; Hakonarson H; Dudbridge F; Humphries SE; Talmud PJ; Kivimäki M; Timpson NJ; Langenberg C; Asselbergs FW; Voevoda M; Bobak M; Pikhart H; Wilson JG; Reiner AP; Keating BJ; Hingorani AD; Sattar N
Lancet; 2015 Jan; 385(9965):351-61. PubMed ID: 25262344
[TBL] [Abstract][Full Text] [Related]
19. Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
Marston NA; Giugliano RP; Im K; Silverman MG; O'Donoghue ML; Wiviott SD; Ference BA; Sabatine MS
Circulation; 2019 Oct; 140(16):1308-1317. PubMed ID: 31530008
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis.
Sabatine MS; Wiviott SD; Im K; Murphy SA; Giugliano RP
JAMA Cardiol; 2018 Sep; 3(9):823-828. PubMed ID: 30073316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
